2016
Total Joint Arthroplasty in Patients with Human Immunodeficiency Virus
Shah KN, Truntzer JN, Touzard Romo F, Rubin LE. Total Joint Arthroplasty in Patients with Human Immunodeficiency Virus. JBJS Reviews 2016, 4: &na;. PMID: 27922987, DOI: 10.2106/jbjs.rvw.15.00117.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusTotal joint arthroplastyImmunodeficiency virusJoint arthroplastyDeep joint infectionActive antiretroviral therapyMajor postoperative complicationsDeep vein thrombosisHIV/AIDSLow CD4Standard prophylaxisAntiretroviral therapyPostoperative complicationsJoint infectionHigh-level studiesOperating surgeonPatientsEffective procedureArthroplastyVirusMost studiesProphylaxisCD4ThrombosisComplications
2005
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors
Page C, Rubin LE, Gusberg RJ, Dardik A. Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors. Journal Of Vascular Surgery 2005, 42: 1014-1018. PMID: 16275464, DOI: 10.1016/j.jvs.2005.06.019.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAcute DiseaseAngiographyFactor VFactor V DeficiencyFibrinolytic AgentsFollow-Up StudiesHeparinHeterozygoteHumansHyperhomocysteinemiaInjections, Intra-ArterialMaleMiddle AgedMutationPeripheral Vascular DiseasesPopliteal ArteryThromboembolismThrombolytic TherapyTissue Plasminogen ActivatorConceptsPeripheral arterial diseaseArterial diseaseArterial thrombosisPre-existing peripheral arterial diseaseAcute popliteal artery thrombosisAcute arterial thrombosisPopliteal artery thrombosisIntra-arterial thrombolysisRisk factor modificationDeep venous thrombosisLong-term treatmentFactor V LeidenArtery thrombosisAcute thrombosisVenous thrombosisHomocysteine levelsFactor modificationV LeidenNormal limitsThrombosisHyperhomocysteinemiaFolic acidDiseaseDisordersAnticoagulation